Sustainable Biotechnology in Pharmaceuticals: Green Approaches and Innovations
医薬品における持続可能なバイオテクノロジー：グリーンアプローチとイノベーション (AI 翻訳)
Pritipragatika Nayak, Suryakanta Swain, H. B. Samal
🤖 gxceed AI 要約
日本語
本レビューは、製薬バイオテクノロジーにおけるグリーンケミストリーと持続可能な戦略の統合を探求。生体触媒、再生可能原料、グリーン溶媒、計算手法などを通じて、環境負荷の低減と効率向上を実現する方法を論じる。また、AI駆動の予測モデリングや規制枠組みなど将来の機会にも言及。
English
This review explores the integration of green chemistry and sustainable strategies in pharmaceutical biotechnology. It discusses biocatalysis, renewable feedstocks, green solvents, and computational approaches to reduce environmental impact and improve efficiency. It also highlights future opportunities including AI-driven predictive modeling and regulatory frameworks.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本の製薬業界では、環境規制の強化やESG投資の拡大に伴い、GXへの対応が求められている。本レビューは製薬プロセスのグリーン化に関する包括的な知見を提供し、日本の企業や研究機関が持続可能な技術を導入する際の参考となる。
In the global GX context
While this paper focuses on pharmaceutical biotechnology, its discussion of green chemistry and sustainable processes aligns with global trends in decarbonizing industrial sectors. It offers insights applicable to green manufacturing and circular economy principles, relevant to GX strategies worldwide.
👥 読者別の含意
🔬研究者:Researchers in pharmaceutical biotechnology or green chemistry can use this review to identify sustainable alternatives and future research directions.
🏢実務担当者:Corporate sustainability teams in the pharmaceutical industry can leverage these green approaches to improve environmental performance and align with ESG criteria.
🏛政策担当者:Policymakers can consider regulatory frameworks that incentivize green chemistry in pharmaceuticals, as discussed in the paper.
📄 Abstract（原文）
Pharmaceutical biotechnology is a rapidly evolving, multidisciplinary field that has transformed drug design and development by integrating biotechnological innovations into clinical practice. While existing literature extensively documents the growth of biotechnology, few reviews have thoroughly explored the intersection of green and sustainable strategies. This review makes a unique contribution by examining how green chemistry-including biocatalysis, renewable feedstocks, green solvents, and computational approaches-is reshaping pharmaceutical biotechnology. Unlike conventional processes, which are often environmentally hazardous and energy-intensive, the integration of green biotechnology provides a sustainable approach that enhances efficiency, reduces toxicity, minimizes waste, and offers viable alternatives for large-scale industrial applications. Furthermore, this article presents a comprehensive perspective highlighting the synergistic potential of green chemistry and biotechnology in redefining drug design and production through the synthesis of diverse innovations. Its value lies in critically assessing not only recent achievements but also persistent challenges, such as cost, scalability, and regulatory hurdles. Looking ahead, this review emphasizes emerging opportunities, including artificial intelligence- driven predictive modeling, catalytic innovations, next-generation green solvents, and regulatory frameworks that support sustainable practices. These initiatives underscore the crucial role of policymakers in advancing a greener, more resilient pharmaceutical sector. Ultimately, the development of sustainable biotechnology is vital for scientific progress, human health, and environmental preservation. Achieving a sustainable future in the pharmaceutical industry will require a collaborative approach to manage rapid market growth while maximizing economic, environmental, and social sustainability.
🔗 Provenance — このレコードを発見したソース
- semanticscholar https://doi.org/10.2174/0122133461424340251204064224first seen 2026-05-15 20:29:59 · last seen 2026-06-15 05:30:42
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。